- Engineered cell lines
- Cas9 stable cell lines
Cas9 Stable Cell Lines
Simplify gene editing experiments with stably expressing Cas9 cell lines
Choose from a range of popular cell line backgrounds, then simply deliver your CRISPR guide RNA for straightforward gene knockout.
CRISPR knockout ready cells
- Generated using Horizon's own Edit-R lentiviral vectors with a Blasticidin resistance selection marker.
- QC verified and validated to ensure stable expression and functionality of Cas9 endonuclease.
- Cells are provided in a pooled format of >1 million cells per vial.
Ideal for use with other Horizon products
For gene editing experiments and loss-of-function studies:
For screening projects
Proven models
Our catalog of cell lines has become a gold-standard resource in antibody validation, cancer research, and early drug-discovery research. Horizon was recently recognized by CiteAb as the Cell Line Supplier to Watch in Cancer Research for 2024. Read more about the CiteAb award.
Limited use agreement
All cell lines engineered by Horizon Discovery are purchased under the terms of our Limited Use Label License.
Cell culture medium and cell line maintenance tips
Cell line background | Cat # | Basal medium | Supplements | Subculturing tips |
---|---|---|---|---|
A549 | HD Cas9-001 | RPMI 1640 | 10% FBS
1% Pen/Strep |
|
HCT-116 | HD Cas9-002
HD dCas9-VPR-002 |
RPMI1640 | 10% FBS
1% Pen/Strep |
|
Jurkat | HD Cas9-004 | RPMI1640 | 10% FBS
1% Pen/Strep |
|
K-562 | HD Cas9-005
HD dCas9-VPR-005 |
IMDM | 10% FBS
1% Pen/Strep |
|
RKO | HD Cas9-007 | RPMI1640 | 10% FBS
1% Pen/Strep |
|
NIH/3T3 | HD Cas9-010 | DMEM, high glucose, GlutaMAXTM | 10% FBS
1% Pen/Strep |
|
HAP1 | HD Cas9-011
HD dCas9-VPR-011 |
IMDM | 10% FBS
1% Pen/Strep |
|
U2OS | HD Cas9-012
HD dCas9-VPR-012 |
DMEM, high glucose | 10% FBS
1% Sodium Pyruvate 1% Pen/Strep |
|
Efficient indel formation using Edit-R™ synthetic sgRNA in Cas9 expressing stable cell lines
Adherent Cas9 Stable Cell Lines were plated at 10,000 cells/well and reverse transfected using DharmaFECT1 or DharmaFECT4 Transfection Reagent with synthetic sgRNA (25 nM) targeting PPIB (Cat # U-009000-01-XX). Cells were harvested 72 hours post-transfection and the relative efficiency of indel formation was assessed using trace decomposition (TIDE) compared to a non-targeting control (NTC; Cat # U-009501-01-XX).
Suspension Cas9 Stable Cell Lines were electroporated using 100,000 cells/well, and Lonza buffer SE or SF, respectively, with synthetic sgRNA (5 µM) targeting PPIB (Cat # U-009000-01-XX). Cells were harvested 72 hours post-transfection and the relative efficiency of indel formation was assessed using trace decomposition (TIDE) compared ion to a non-targeting control (NTC; Cat # U-009501-01-XX).